The Tumor Inhibitor and Antiangiogenic Agent Withaferin A Targets the Intermediate Filament Protein Vimentin
Top Cited Papers
- 22 June 2007
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 14 (6), 623-634
- https://doi.org/10.1016/j.chembiol.2007.04.010
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculatureBlood, 2006
- A Chemical and Genetic Approach to the Mode of Action of FumagillinChemistry & Biology, 2006
- Small Molecule Anti-Angiogenic Probes of the Ubiquitin Proteasome Pathway: Potential Application to Choroidal NeovascularizationInvestigative Opthalmology & Visual Science, 2006
- In-vitro and in-vivo assays for angiogenesis-modulating drug discovery and developmentJournal of Pharmacy and Pharmacology, 2006
- How Can (−)-Epigallocatechin Gallate from Green Tea Prevent HIV-1 Infection? Mechanistic Insights from Computational Modeling and the Implication for Rational Design of Anti-HIV-1 Entry InhibitorsThe Journal of Physical Chemistry B, 2006
- Impairment of the ubiquitin‐proteasome system in desminopathy mouse heartsThe FASEB Journal, 2005
- Withaferin A is a potent inhibitor of angiogenesisAngiogenesis, 2004
- Vimentin and desmin of a cartilaginous fish, the shark Scyliorhinus stellaris: Sequence, expression patterns and in vitro assemblyEuropean Journal of Cell Biology, 2001
- Characterization of Disulfide Crosslink Formation of Human Vimentin at the Dimer, Tetramer, and Intermediate Filament LevelsJournal of Structural Biology, 1996
- Mice lacking vimentin develop and reproduce without an obvious phenotypeCell, 1994